TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 159 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $662,000 | -54.2% | 8,797 | -83.7% | 0.00% | -33.3% |
Q1 2022 | $1,446,000 | +588.6% | 53,847 | +1606.7% | 0.01% | +500.0% |
Q3 2021 | $210,000 | -64.2% | 3,155 | -49.0% | 0.00% | -66.7% |
Q1 2021 | $586,000 | +181.7% | 6,190 | +262.0% | 0.00% | +50.0% |
Q4 2020 | $208,000 | -51.5% | 1,710 | -65.1% | 0.00% | -66.7% |
Q3 2020 | $429,000 | +51.1% | 4,905 | -23.0% | 0.01% | -14.3% |
Q1 2020 | $284,000 | -72.9% | 6,370 | -62.1% | 0.01% | +16.7% |
Q4 2019 | $1,048,000 | +112.6% | 16,820 | +28.3% | 0.01% | +50.0% |
Q3 2019 | $493,000 | – | 13,112 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |